# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA1809039 | 11a | Tmax/dose | = | 3.1 | hr | ALA1810383 | hr | Rattus norvegicus | |||
2. | ALA1809039 | 11a | Cmax/dose | = | 137 | nM | ALA1810382 | nM | Rattus norvegicus | |||
3. | ALA1809039 | 11a | F | = | 97 | % | ALA1810381 | % | Rattus norvegicus | |||
4. | ALA1809039 | 11a | AUC/dose | = | 2658 | nM.hr | ALA1810333 | nM.hr | Rattus norvegicus | |||
5. | ALA1809039 | 11a | AUC/dose | = | 2729 | nM.hr | ALA1810332 | nM.hr | Rattus norvegicus | |||
6. | ALA1809039 | 11a | beta t1/2 | = | 8.9 | hr | ALA1810331 | hr | Rattus norvegicus | |||
7. | ALA1809039 | 11a | Vdss(app) | = | 8.3 | L/Kg | ALA1810330 | L.kg-1 | Rattus norvegicus | |||
8. | ALA1809039 | 11a | CL | = | 13 | ml/min.kg | ALA1810329 | mL.min-1.kg-1 | Rattus norvegicus | |||
9. | ALA1809039 | 11a | IC50 | > | 30 | uM | ALA1810316 | nM | Homo sapiens | |||
10. | ALA1809039 | 11a | solubility | > | 1 | mM | ALA1810328 | nM | ||||
11. | ALA1809039 | 11a | IC50 | > | 2500 | nM | ALA1810327 | nM | ||||
12. | ALA1809039 | 11a | IC50 | > | 2500 | nM | ALA1810326 | nM | ||||
13. | ALA1809039 | 11a | IC50 | > | 2500 | nM | ALA1810325 | nM | ||||
14. | ALA1809039 | 11a | Fu | = | 7 | % | ALA1810324 | Homo sapiens | ||||
15. | ALA1809039 | 11a | Fu | = | 4 | % | ALA1810323 | Rattus norvegicus | ||||
16. | ALA1809039 | 11a | IC50 | = | 5 | nM | ALA1810317 | 8.30 | nM | Rattus norvegicus | ||
17. | ALA1809039 | 11a | IC50 | = | 2 | nM | ALA1810321 | 8.70 | nM | Mus musculus | ||
18. | ALA1809039 | 11a | IC50 | = | 2 | nM | ALA1810320 | 8.70 | nM | Homo sapiens | ||
19. | ALA1809039 | 11a | IC50 | = | 2 | nM | ALA1810319 | 8.70 | nM | Homo sapiens |